R&D Systems™ Recombinant Human B7-H2 Isoform 3 Fc Chimera Protein

Catalog No.	Quantity
10-028-B7100	100 μg

Catalog No. 10-028-B7100 Supplier R&D Systems™ Supplier No. 10028B7100

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Human ICOS Fc Chimera is immobilized at 5 μg/mL, Recombinant Human B7-H2 Isoform 3 Fc Chimera binds with an ED50 of 10-50 μg/mL.

Specifications

• Accession Number: O75144-3
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 23308
• Molecular Weight (g/mol): M.W. (Observed): 57-66 kDa, reducing conditions; M.W. (theoretical): 40 kDa
• Quantity: 100 μg
• Source: Mouse myeloma cell line, NS0-derived human B7-H2 protein Human B7-H2 Isoform 3 (Ala19-Thr139) (N-terminus) Accession # O75144-3 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: B7-H2/ICOSLG
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: B7-H2/ICOSLG